Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyOleksandr Korotych, Askar Yedilbayev, Nana Kiria et al.|The Lancet Infectious Diseases|2024Cited by 23
Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, UzbekistanJamshid Gadoev, Masoud Dara, Kallibek Kudaybergenov et al.|International Journal of Environmental Research and Public Health|2021Cited by 9